FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

José María García-Arenzana

Research Profile

Procedures

Living Beings

Geographic Areas

Spain

Physiology

Disorders

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Emilio Pérez-Trallero; José María Marimón; Marta Alonso; María Ercibengoa; José María García-Arenzana
Decline and rise of the antimicrobial susceptibility of Streptococcus pneumoniae isolated from middle ear fluid in children: influence of changes in circulating serotypes.
Emilio Pérez-Trallero; Esther Tamayo; Milagrosa Montes; José María García-Arenzana; Victor Iriarte
In vitro activities of retapamulin and 16 other antimicrobial agents against recently obtained Streptococcus pyogenes isolates.
Emilio Pérez-Trallero; Milagrosa Montes; Beatriz Orden; Esther Tamayo; José María García-Arenzana; José María Marimón
Phenotypic and genotypic characterization of Streptococcus pyogenes isolates displaying the MLSB phenotype of macrolide resistance in Spain, 1999 to 2005.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of José María García-Arenzana (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Emilio Pérez-Trallero; José María Marimón; Marta Alonso; María Ercibengoa; José María García-Arenzana
Decline and rise of the antimicrobial susceptibility of Streptococcus pneumoniae isolated from middle ear fluid in children: influence of changes in circulating serotypes.
Antimicrobial agents and chemotherapy 2012;56(7):3989-91.
2011: Emilio Pérez-Trallero; Esther Tamayo; Milagrosa Montes; José María García-Arenzana; Victor Iriarte
In vitro activities of retapamulin and 16 other antimicrobial agents against recently obtained Streptococcus pyogenes isolates.
Antimicrobial agents and chemotherapy 2011;55(5):2406-8.
2007: Emilio Pérez-Trallero; Milagrosa Montes; Beatriz Orden; Esther Tamayo; José María García-Arenzana; José María Marimón
Phenotypic and genotypic characterization of Streptococcus pyogenes isolates displaying the MLSB phenotype of macrolide resistance in Spain, 1999 to 2005.
Antimicrobial agents and chemotherapy 2007;51(4):1228-33.
2005: José María Marimón; Adoración Valiente; María Ercibengoa; José María García-Arenzana; Emilio Pérez-Trallero
Erythromycin resistance and genetic elements carrying macrolide efflux genes in Streptococcus agalactiae.
Antimicrobial agents and chemotherapy 2005;49(12):5069-74.
2005: María José Ferrándiz; Carmen Ardanuy; Josefina Liñares; José María García-Arenzana; Emilia Cercenado; Ana Fleites; Adela G de la Campa
New mutations and horizontal transfer of rpoB among rifampin-resistant Streptococcus pneumoniae from four Spanish hospitals.
Antimicrobial agents and chemotherapy 2005;49(6):2237-45.
2004: Emilio Pérez-Trallero; José María Marimón; Alberto Gonzalez; Diego Vicente; José María García-Arenzana
Spectrum of antibiotic resistance of the Spain14-5 Streptococcus pneumoniae clone over a 22 year period.
The Journal of antimicrobial chemotherapy 2004;53(4):620-5.
2002: L Iglesias Sánchez; Eduardo G Pérez-Yarza; José María García-Arenzana; A Valiente Méndez; E Pérez-Trallero
[Epidemiology of invasive pneumococcal disease in children in Gipuzkoa (Spain) from 1981 to 2001].
Anales españoles de pediatría 2002;57(5):401-7.
2002: Luis Iglesias; José María García-Arenzana; Adoración Valiente; María Gomariz; Emilio Pérez-Trallero
Yersinia enterocolitica O:3 infection of a prosthetic knee joint related to recurrent hemarthrosis.
Scandinavian journal of infectious diseases 2002;34(2):132-3.
1998: Emilio Pérez-Trallero; M Alkorta; José María García-Arenzana; A Iturzaeta; María Gomariz
In-vitro, in-vivo and ex-vivo studies with oral beta-lactams against Streptococcus pneumoniae.
The Journal of antimicrobial chemotherapy 1998;41(6):629-34.